Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this trial is to determine whether suppressing neutrophil function by CXCR2 inhibition using the drug AZD5069, in patients following PCI for atherosclerotic coronary disease, will give rise to improvement in coronary artery function (as assessed by PET scanning).
Critère d'inclusion
- Coronary Heart Disease